Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SWATH data for human keratinocytes treated with erastin and reactive carbonyl species

ABSTRACT: SWATH-MS data for human keratinocytes (HaCaT cell line), sample 001-004 indicates HaCaT cells with no treatment, sample 005-008 indicates HaCaT cells induced by erastin, sample 009-012 indicates HaCaT cells induced by erastin plus MGO (methyglyoxal), and sample 013-016 indicates HaCaT cells induced by erastin plus GO (glyoxal). For more detailed information, please contact Dr.Chang Liu (hichang813@uri.edu)

INSTRUMENT(S): AB Sciex TripleTOF 5600 mass spectrometer

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Navindra Seeram

PROVIDER: MSV000093197 | MassIVE | Thu Oct 26 06:21:00 BST 2023

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Anti-Inflammatory and Antioxidant Properties of Oleuropein in Human Keratinocytes Characterized by Bottom-Up Proteomics

Project description:SWATH-MS data for human keratinocytes (HaCaT cell line), sample 0001-0004 indicates HaCaT cells with no treatment, sample 0005-0008 indicates HaCaT cells induced by H2O2, sample 0009-0012 indicates HaCaT cells treated by H2O2 and OLE. For more detailed information, please contact Dr.Chang Liu (hichang813@uri.edu)

2024-12-25 | MSV000096730 | MassIVE

Anti-Ferroptotic Effect of Cannabidiol in Human Skin Keratinocytes Characterized by Data-Independent Acquisition-Based Proteomics

Project description:SWATH-MS data for human keratinocytes (HaCaT cell line), sample 010-012 indicates HaCaT cells with no treatment, sample 013-015 indicates HaCaT cells induced by erastin, sample 0016-018 indicates HaCaT cells treated by erastin and CBD. For more detailed information, please contact Dr.Chang Liu (hichang813@uri.edu)

2024-03-18 | MSV000094348 | MassIVE

directDIA analysis for mouse liver

Project description:SWATH data for mouse, sample 001-004 is control, sample 005-008 is model (LPS-induced peritonitis), and sample 009-012 is maple syrup extract-treated (LPS induction plus maple syrup extract administration). For more detailed information, please contact Dr.Chang Liu (hichang813@uri.edu)

2023-06-13 | MSV000092153 | MassIVE

directDIA analysis for mouse kidney

2023-06-24 | MSV000092259 | MassIVE

GNPS - directDIA analysis for mouse kidney

2023-06-24 | MSV000092259 | GNPS

GNPS - directDIA analysis for mouse liver

2023-06-13 | MSV000092153 | GNPS

Project description:sample-001

| PRJNA702150 | ENA

Gene expression profiling of cidofovir treatment and resistance inHeLa, HaCaT, and PHK cells

Project description:Cidofovir is an acyclic nucleoside phosphonate with strong antiviral activity against a broad spectrum of DNA viruses. Although it has previously been shown that cidofovir exerts an antiproliferative effect on HPV positive cells by the induction of apoptosis, the exact mechanism of action remains to be unraveled. In order to study the activity of cidofovir against HPV, gene expression profiling was performed in cidofovir-treated and cidofovir-resistant HeLa, HaCaT, and PHK cells by means of microarrays (HG-U133 Plus 2, Affymetrix). Controls (untreated HeLa, HaCaT, and PHK wild-type cells): 72h of growth. Cidofovir treated (50 M-BM-5g/ml) HeLa, HaCaT, and PHK cells: 72h of growth. Cidofovir resistant cells (HeLa #52 and HaCaT #51): 72h of growth. All samples were performed in triplicates.

2013-07-03 | E-GEOD-39293 | biostudies-arrayexpress

RNAseq analysis of treatment-resistant and sensitive breast cancer patient-derived organoids with paclitaxel treatments

Project description:Huntsman Cancer Institute (HCI)-001 patient-derived organoids (PDOs) and HCI-002 PDOs obtained from Huntsman Cancer Institute, University of Utah (Nat Med. 2011 Oct 23;17(11):1514-20). Purpose: The goals of this study is to identify molecular pathways and genes that are involved in the treatment responsiveness of breast cancer PDOs. Methods: mRNA profiles of HCI-001 and HCI-002 PDOs were generated by Illumina NovaSeq 6000 platform for paired-end sequencing, 150-bp read length, for about 20 million raw reads per sample. RNA sequencing FASTQ files were processed with HISAT2 aligner in default mode with the Ensembl human transcriptome annotation (Build version GRCh38 and transcript annotation GRCh38.89). Differential gene expression analysis was performed using DESeq2 software. Enrichment analysis was performed using ClusterProfiler software. Results: We mapped about 20 million sequence reads per sample to the human genome (build HG38) in the RNAs of HCI-001 and HCI-002 PDOs treated with paclitaxel or vehicle. We used a minimum expression cut-off of 1 FPKM in order to exclude low-levels genes and the RNA-seq data confirmed the difference expression of 67 known apoptosis-regulatory genes in treatment-sensitive PDOs (HCI-002) compare to treatment-resistant PDOs (HCI-001). Conclusions: This study identified apoptosis-regulatory genes that are differentially induced or represeed in treatment-sensitive PDOs (HCI-002) or treatment-resistant PDOs (HCI-001).

2021-09-09 | GSE183477 | GEO

Effect of Lycium barbarum polysaccharide-glycoprotein(LBP) on irradiated HaCaT cells

Project description:To investigate the protective effect of Lycium barbarum polysaccharide-glycoprotein (LBP) in the radiation-induced HaCaT cell injury, We performed gene expression profiling analysis using data obtained from RNA-seq of HaCaT cells at 3h after radiation.

2024-06-01 | GSE218507 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data